- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Clinical Trials
- April 2025
- 50 Pages
Global
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2024
- 30 Pages
Global
From €2503EUR$2,750USD£2,126GBP
- Report
- September 2024
- 343 Pages
Global
From €7236EUR$7,950USD£6,146GBP
- Report
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- May 2021
- 50 Pages
China
From €2366EUR$2,600USD£2,010GBP
- Report
- March 2023
- 147 Pages
Global
From €4504EUR$4,949USD£3,826GBP
- Report
- November 2023
- 135 Pages
Global
From €3641EUR$4,000USD£3,092GBP
- Report
- April 2023
- 117 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- January 2023
- 85 Pages
Europe
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2024
- 156 Pages
United States
€3459EUR$3,800USD£2,938GBP
- Report
- January 2024
- 114 Pages
United States
€3186EUR$3,500USD£2,706GBP
- Report
- July 2018
- 33 Pages
Global
From €9102EUR$10,000USD£7,731GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£387GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,049GBP
- Report
- December 2022
- 210 Pages
Global
From €2351EUR$2,583USD£1,997GBP
€3359EUR$3,690USD£2,853GBP

Tiotropium is a long-acting anticholinergic drug used to treat chronic obstructive pulmonary disease (COPD). It is a bronchodilator, meaning it relaxes the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both an inhaler and a dry powder inhaler. Tiotropium is the only long-acting anticholinergic approved for the treatment of COPD. It is also used to treat asthma and other respiratory conditions.
Tiotropium is a popular drug in the respiratory drugs market, as it is effective in treating COPD and other respiratory conditions. It is also well-tolerated, with few side effects. It is available in both generic and brand-name forms, making it accessible to a wide range of patients.
Some companies in the Tiotropium market include Boehringer Ingelheim, GlaxoSmithKline, and Novartis. Show Less Read more